Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial
Fingerprint
Dive into the research topics of 'Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial'. Together they form a unique fingerprint.